HMGB1 released from CRC cells in response to chemotherapy-induced damage promotes MT of BM-MSCs to CRC cells, resulting in enhanced stemness and anticancer drug resistance in CRC cells. The gene discussed is HMGB1; the disease is colorectal carcinoma.